✦ LIBER ✦

Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period

✍ Scribed by Bárcena, Rafael; Moreno, Ana; Rodríguez-Gandía, Miguel Angel; Albillos, Agustín; Arocena, Carlos; Blesa, Carlos; García-Hoz, Fernando; Graus, Javier; Nuño, Javier; López-Hervás, Pedro; Gajate, Luis; Martínez, Adolfo; Bermejo, Teresa; Mateos, María Luisa; del Campo, Santos

Book ID: 121468947
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 594 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.10.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

176 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIN

176 PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY EVALUATING EFFICACY AND SAFETY OF INTRAVENOUS SILIBININ IN PATIENTS WITH HCV RECURRENCE ON THE GRAFT AFTER LIVER TRANSPLANTATION

✍ Rendina, M.; D'Amato, M.; Castellaneta, A.; Castellaneta, N.M.; Brambilla, N.; G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

T-48 Efficacy and safety of intravenous

T-48 Efficacy and safety of intravenous silibinin in patients with HCV recurrence on the graft after liver transplantation (LT): a prospective, randomized, double-blind, placebo-controlled pilot study

✍ Rendina, M.; D'Amato, M.; Castellaneta, A.; Castellaneta, N.M.; Brambilla, N.; G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P.1.197: HCV GENOTYPE 1 AND 4 TREATMENT

P.1.197: HCV GENOTYPE 1 AND 4 TREATMENT IN LIVER TRANSPLANTED AND IN HIV COINFECTED PATIENTS: EFFECTS OF IMMUNOSUPPRESSION ON THE RESPONSE TO THERAPY

✍ F.R. Ponziani; S. Di Giambenedetto; M. Siciliano; B.E. Annicchiarico; M. Pompili 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB